T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
LEXINGTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing...
Day: April 12, 2024
Sotera Health Announces First-Quarter 2024 Earnings Release Date
CLEVELAND, April 11, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization...
Nurix Therapeutics Announces Proposed Public Offering
SAN FRANCISCO, April 11, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein...
Power to the Palate: Capitol 9 THC Seltzers Mix Weed & Political Wit for Buzzy Summer Sipping
For Americans who enjoy cannabis and roll their eyes at U.S. politics, Capitol 9 proudly presents politically themed THC seltzers...
Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with Sepsis
Nes-Ziona, Israel, April 11, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy...
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC Leuven, BELGIUM – April 11, 2024 – 07:00 PM CET Oxurion...
Transparency Notifications from Shareholders
PRESS RELEASEREGULATED INFORMATION 11 April 2024, 06:00 pm CEST Ghent, Belgium – 11 April 2024 – Sequana Medical NV (Euronext...
CBD of Denver Inc. Announces New Advisory Board Member for Luxora
Denver, Colorado--(Newsfile Corp. - April 12, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced that John Barnet...
NHI Announces First Quarter 2024 Earnings Release and Conference Call Date
MURFREESBORO, TN / ACCESSWIRE / April 12, 2024 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of...
Cosmo and Medtronic Unveil the Future of AI in GI: Genius Summit 2024 Reveals Innovations and Collaborations That Advance Endoscopic Care
Dublin, Ireland--(Newsfile Corp. - April 12, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announces that Medtronic plc...